XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net loss $ (147,305) $ (101,878) $ (25,570)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 3,265 1,147 798
Impairment of inventories 1,664 0 0
Loss on write down of fixed assets 0 52 0
Change in fair value of warrant liability (970) (1,954) 0
Stock-based compensation 24,247 22,237 3,806
Amortization of right-of-use assets 2,882 1,901 0
Realized loss on available-for-sale securities 29 0 0
Amortization of premium on available-for-sale securities 389 1,498 0
Accounts receivable (546) (2,200) 228
Inventories (2,552) (844) (865)
Other current assets 3,634 (7,285) (3,513)
Other noncurrent assets (3) (795) (5)
Accounts payable 1,287 2,667 1,360
Accrued liabilities 4,953 3,202 2,263
Accrued employee costs 2,525 1,474 256
Lease liability (2,871) (1,785) 0
Other current liabilities (539) 458 5
Other noncurrent liabilities 0 0 6
Net cash used in operating activities (109,911) (82,105) (21,231)
Cash flows from investing activities:      
Purchase of property, plant, and equipment (7,439) (3,850) (855)
Purchase of available-for-sale securities (210,197) (571,925) 0
Proceeds from sale of available-for-sale securities 0 20,123 0
Proceeds from maturities of available-for-sale securities 328,526 171,580 0
Purchase of intangible assets 0 (4,500) 0
Net cash provided by (used in) investing activities 110,890 (388,572) (855)
Cash flows from financing activities:      
Proceeds from business combination and private offering 0 560,777 0
Transaction costs related to business combination and private offering 0 (47,487) 0
Payments of taxes withheld on net settled vesting of restricted stock units (720) (1,338) 0
Proceeds from exercise of stock options 350 911 73
Proceeds from exercise of warrants 1 0  
Net cash provided by (used in) financing activities (369) 512,863 73
Net increase (decrease) in cash and cash equivalents 610 42,186 (22,013)
Beginning cash and cash equivalents 66,810 24,624 46,637
Ending cash and cash equivalents 67,420 66,810 24,624
Supplemental disclosures of cash flow information:      
Cash paid for interest 0 0 0
Cash paid for income taxes 0 0 0
Supplemental disclosure of noncash investing and financing activities:      
Unpaid property, plant and equipment purchases 79 796 2
Private placement of warrants acquired as part of merger 0 3,014 0
Right-of-use asset obtained in exchange for lease liability 0 10,515 0
Non-cash lease adoption $ 0 $ 1,671 $ 0